June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Ocular straylight and contrast sensitivity in HIV-positive patients compared with normal subjects
Author Affiliations & Notes
  • Nazli Demirkaya
    Ophthalmology, Academic Medical Center Amsterdam, Amsterdam, Netherlands
  • Thomas Van Den Berg
    Ocular Signal Transduction, Netherlands Institute for Neuroscience, Amsterdam, Netherlands
  • Stanley Darma
    Ophthalmology, Academic Medical Center Amsterdam, Amsterdam, Netherlands
  • Reinier Schlingemann
    Ophthalmology, Academic Medical Center Amsterdam, Amsterdam, Netherlands
  • Frank Verbraak
    Ophthalmology, Academic Medical Center Amsterdam, Amsterdam, Netherlands
    Biomedical Engineering and Physics, Academic Medical Center Amsterdam, Amsterdam, Netherlands
  • Footnotes
    Commercial Relationships Nazli Demirkaya, None; Thomas Van Den Berg, Oculus GmbH (P); Stanley Darma, None; Reinier Schlingemann, None; Frank Verbraak, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2911. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nazli Demirkaya, Thomas Van Den Berg, Stanley Darma, Reinier Schlingemann, Frank Verbraak; Ocular straylight and contrast sensitivity in HIV-positive patients compared with normal subjects. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2911. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To assess ocular straylight values and spatial and temporal contrast sensitivity in HIV-positive patients compared with normal subjects

Methods: 75 HIV-positive patients, well controlled using cART, and 50 healthy, age and socio-economically matched controls were enrolled in this study. Participants with a history of retinitis or any other disease known to influence the retina were excluded. After exclusion, 63 HIV-positive patients and 39 controls were evaluated. Spatial contrast sensitivity was examined using the Pelli Robson (PR) chart. Ocular straylight was assessed with the Oculus C-Quant device. Temporal contrast sensitivity (TCS), as measure for retinal sensitivity without confounding by optics, was assessed with custom made software, implemented using the C-Quant hardware. Only one eye of each participant was selected for analysis

Results: The patient group had a significantly lower PR score compared with the controls (1.89±0.1 vs 1.94±0.04 logCS; p=0.017) but no difference in TCS was found between both groups (2.13±0.16 vs 2.14±0.16 logTCS; p=0.753). Straylight values were significant higher in patients (1.19±0.18 vs 1.11±0.15 log(s); p=0.032)

Conclusions: The higher straylight value might be attributed to media opacities, e.g. development of cataract, since HIV-positive patients have been reported to have a higher incidence of cataract surgery, caused possibly by accelerated aging. The discrepancy in PR scores and TCS values could be ascribed to the fact that PR outcome is influenced by both optical and retinal components, while TCS assesses purely retinal function

Keywords: 415 AIDS/HIV • 478 contrast sensitivity • 445 cataract  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×